Literature DB >> 6335683

Toxicity and side-effects of antimalarials in Africa: a critical review.

L A Salako.   

Abstract

Notwithstanding the presence of resistance to chloroquine in some parts of Africa, this drug is still the most widely used antimalarial in the continent. One adverse reaction of chloroquine that has an important bearing on its use is pruritus. The risk of increasing the incidence of ocular toxicity through prolonged use of chloroquine for prophylaxis must be borne in mind by physicians. Another antimalarial that is likely to be used in increasing amounts in Africa is pyrimethamine-sulfadoxine. With prolonged use of this combination for prophylaxis, the adverse reactions usually associated with the long-acting sulfonamides are possible.Genetic abnormalities may also play a part in the incidence and severity of adverse reactions to certain drugs, e.g., primaquine and quinine. Most of the common adverse reactions are mild and have little or no influence on the acceptability and utilization of the drugs, with the exception of chloroquine-induced pruritus. Studies to define the precise epidemiology and pathophysiology of this reaction are urgently needed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6335683      PMCID: PMC2536191     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  28 in total

1.  A PATTERN OF PRURITUS DUE TO CHLOROQUINE.

Authors:  O L EKPECHI; A N OKORO
Journal:  Arch Dermatol       Date:  1964-04

2.  Chloroquine-induced involuntary movements.

Authors:  S Singhi; P Singhi; M Singh
Journal:  Br Med J       Date:  1977-08-20

3.  Extrapyramidal syndrome following chloroquine therapy.

Authors:  S Singhi; P Singhi; M Singh
Journal:  Indian J Pediatr       Date:  1979-02       Impact factor: 1.967

4.  Serious reactions during malaria prophylaxis with pyrimethamine-sulfadoxine.

Authors:  V V Olsen; S Loft; K D Christensen
Journal:  Lancet       Date:  1982-10-30       Impact factor: 79.321

5.  Chloroquine induced involuntary movements.

Authors:  E M Umez-Eronini; E A Eronini
Journal:  Br Med J       Date:  1977-04-09

6.  Drug toxicity of the inner ear.

Authors:  R L Hybels
Journal:  Med Clin North Am       Date:  1979-03       Impact factor: 5.456

7.  Pigmentary skin changes associated with ocular chloroquine toxicity in Ghana.

Authors:  K O Bentsi-Enchill
Journal:  Trop Geogr Med       Date:  1980-09

8.  Cardiac arrest after intravenous chloroquine injection.

Authors:  H Abu-Aisha; H M Abu-Sabaa; T Nur
Journal:  J Trop Med Hyg       Date:  1979-02

9.  Lack of correlation between melanin affinity and retinopathy in mice and cats treated with chloroquine or flunitrazepam.

Authors:  H Kuhn; P Keller; E Kovács; A Steiger
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1981

10.  Kinetics of the uptake and elimination of chloroquine in children with malaria.

Authors:  S A Adelusi; A H Dawodu; L A Salako
Journal:  Br J Clin Pharmacol       Date:  1982-10       Impact factor: 4.335

View more
  9 in total

Review 1.  Drug treatment and prevention of malaria.

Authors:  N J White
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 2.  Treatment of malaria--1990.

Authors:  D M Panisko; J S Keystone
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

Review 3.  Antiparasitic drugs in children.

Authors:  N J White
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

4.  Effect of artemether on hematological parameters of healthy and uninfected adult Wistar rats.

Authors:  I O Osonuga; O A Osonuga; A Osonuga; A A Onadeko; A A Osonuga
Journal:  Asian Pac J Trop Biomed       Date:  2012-06

5.  Mefloquine-associated dizziness, diplopia, and central serous chorioretinopathy: a case report.

Authors:  Manish Jain; Remington L Nevin; Iajaz Ahmed
Journal:  J Med Case Rep       Date:  2016-10-31

6.  Hydroxychloroquine as antiviral prophylaxis for exposed caregivers to Covid-19: An urgent appraisal is needed.

Authors:  Rachid Tahiri Joutei Hassani; Ahmed Bennis
Journal:  J Infect Public Health       Date:  2020-05-11       Impact factor: 3.718

7.  Repositioning chloroquine as antiviral prophylaxis against COVID-19: potential and challenges.

Authors:  Raymond Chang; Wei-Zen Sun
Journal:  Drug Discov Today       Date:  2020-07-03       Impact factor: 7.851

8.  AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised, phase 2, non-inferiority clinical trial.

Authors:  Ousmane A Koita; Lansana Sangaré; Haiyan D Miller; Aliou Sissako; Moctar Coulibaly; Trevor A Thompson; Saharé Fongoro; Youssouf Diarra; Mamadou Ba; Ababacar Maiga; Boubakar Diallo; David M Mushatt; Frances J Mather; Jeffrey G Shaffer; Asif H Anwar; Donald J Krogstad
Journal:  Lancet Infect Dis       Date:  2017-09-12       Impact factor: 71.421

9.  Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements.

Authors:  Giorgio Frega; Andrea Palloni; Giuseppe Di Pasquale; Gioconda Saccoccio; Alessandro Rizzo; Elisabetta Poluzzi; Primiano Iannone; Giovanni Brandi
Journal:  Front Pharmacol       Date:  2020-10-28       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.